Literature DB >> 559366

Central serous retinopathy.

A Dellaporta.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 559366      PMCID: PMC1311508     

Source DB:  PubMed          Journal:  Trans Am Ophthalmol Soc        ISSN: 0065-9533


× No keyword cloud information.
  8 in total

1.  MACULAR DISEASES: DIAGNOSIS. FLUORESCEIN IN THE STUDY OF MACULAR DISEASE.

Authors:  E W NORTON; J D GASS; J L SMITH; V T CURTIN; N J DAVID; J JUSTICE
Journal:  Trans Am Acad Ophthalmol Otolaryngol       Date:  1965 Jul-Aug

2.  MACULAR DISEASES: PATHOGENESIS.

Authors:  A E MAUMENEE
Journal:  Trans Am Acad Ophthalmol Otolaryngol       Date:  1965 Jul-Aug

3.  Macular and extramacular serous chorieretinopathy. With remarks upon the role of an extrabulbar mechanism in its pathogenesis.

Authors:  B A KLIEN
Journal:  Am J Ophthalmol       Date:  1961-02       Impact factor: 5.258

4.  Central serous retinopathy.

Authors:  G BENNETT
Journal:  Br J Ophthalmol       Date:  1955-10       Impact factor: 4.638

5.  Photocoagulation of macular lesions.

Authors:  J D Gass
Journal:  Trans Am Acad Ophthalmol Otolaryngol       Date:  1971 May-Jun

6.  Central serous retinitis. A follow-up study.

Authors:  I Norholm
Journal:  Acta Ophthalmol (Copenh)       Date:  1969

7.  Doyne Memorial Lecture. Fluorescein angiography in the diagnosis and treatment of lesions of the ocular fundus.

Authors:  A E Maumenee
Journal:  Trans Ophthalmol Soc U K       Date:  1969

8.  Experience with nontreatment of central serous choroidopathy.

Authors:  M L Klein; E M Van Buskirk; E Friedman; E Gragoudas; S Chandra
Journal:  Arch Ophthalmol       Date:  1974-04
  8 in total
  6 in total

1.  Long-term follow-up of a prospective trial of argon laser photocoagulation in the treatment of central serous retinopathy.

Authors:  L Ficker; G Vafidis; A While; P Leaver
Journal:  Br J Ophthalmol       Date:  1988-11       Impact factor: 4.638

2.  Type A behavior and central serous chorioretinopathy.

Authors:  L A Yannuzzi
Journal:  Trans Am Ophthalmol Soc       Date:  1986

3.  Angiographic characteristics of central serous chorioretinopathy in an Egyptian population.

Authors:  Maha M Shahin
Journal:  Int J Ophthalmol       Date:  2013-06-18       Impact factor: 1.779

Review 4.  Bullous variant of idiopathic central serous chorioretinopathy.

Authors:  D K Sahu; P Namperumalsamy; G F Hilton; N F de Sousa
Journal:  Br J Ophthalmol       Date:  2000-05       Impact factor: 4.638

5.  Endogenous cortisol profile in patients with central serous chorioretinopathy.

Authors:  S P Garg; T Dada; D Talwar; N R Biswas
Journal:  Br J Ophthalmol       Date:  1997-11       Impact factor: 4.638

6.  Long-term follow-up of central serous chorioretinopathy.

Authors:  C M Gilbert; S L Owens; P D Smith; S L Fine
Journal:  Br J Ophthalmol       Date:  1984-11       Impact factor: 4.638

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.